Transforming growth factor-β (TGF-β) initially acts as a tumour suppressor in the process of oncogenesis by inhibiting cell proliferation, maintaining tissue architecture, decreasing genomic instability and inducing cell arrest and apoptosis [5–7]. This evidence concerns the gene TGFB1 and neoplasm.